These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI. Kim Y, Cho HH, Kim ST, Park H, Nam D, Kong DS. Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517 [Abstract] [Full Text] [Related]
25. Case report of an elderly woman with atypical imaging for primary central nervous system lymphoma who needed a brain biopsy for diagnosis. Matsuzono K, Yagisawa T, Ohtani K, Ishishita Y, Yamaguchi T, Mashiko T, Ozawa T, Koide R, Tanaka R, Kawai K, Fujimoto S. J Int Med Res; 2021 Aug; 49(8):3000605211035197. PubMed ID: 34461767 [Abstract] [Full Text] [Related]
26. Balanced transformer: efficient classification of glioblastoma and primary central nervous system lymphoma. Wang S, Wu J, Chen M, Huang S, Huang Q. Phys Med Biol; 2024 Feb 15; 69(4):. PubMed ID: 38232389 [Abstract] [Full Text] [Related]
27. Machine Learning-based Texture Analysis of Contrast-enhanced MR Imaging to Differentiate between Glioblastoma and Primary Central Nervous System Lymphoma. Kunimatsu A, Kunimatsu N, Yasaka K, Akai H, Kamiya K, Watadani T, Mori H, Abe O. Magn Reson Med Sci; 2019 Jan 10; 18(1):44-52. PubMed ID: 29769456 [Abstract] [Full Text] [Related]
30. Primary central nervous system lymphoma with systemic metastasis: case report and review. Brown MT, McClendon RE, Gockerman JP. J Neurooncol; 1995 Jan 10; 23(3):207-21. PubMed ID: 7673983 [Abstract] [Full Text] [Related]
31. Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma. Hatzoglou V, Oh JH, Buck O, Lin X, Lee M, Shukla-Dave A, Young RJ, Peck KK, Vachha B, Holodny AI, Grommes C. J Neurooncol; 2018 Nov 10; 140(2):351-358. PubMed ID: 30073640 [Abstract] [Full Text] [Related]
34. Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: utility of intravoxel incoherent motion MR imaging. Suh CH, Kim HS, Lee SS, Kim N, Yoon HM, Choi CG, Kim SJ. Radiology; 2014 Aug 10; 272(2):504-13. PubMed ID: 24697149 [Abstract] [Full Text] [Related]
35. Is deep brain involvement in intracranial primary central nervous system lymphoma of importance for penetration of chemotherapeutic agents? Meling TR, Latysheva A, Da Broi M, Jahr G, Holte H, Beiske K, Emblem KE. Neuroradiology; 2018 Jul 10; 60(7):703-713. PubMed ID: 29804159 [Abstract] [Full Text] [Related]
37. The combination of 13N-ammonia and 18F-FDG in predicting primary central nervous system lymphomas in immunocompetent patients. Shi X, Zhang X, Yi C, Wang X, Chen Z, Zhang B. Clin Nucl Med; 2013 Feb 10; 38(2):98-102. PubMed ID: 23334122 [Abstract] [Full Text] [Related]
38. Imaging of primary central nervous system lymphoma. Tang YZ, Booth TC, Bhogal P, Malhotra A, Wilhelm T. Clin Radiol; 2011 Aug 10; 66(8):768-77. PubMed ID: 21513925 [Abstract] [Full Text] [Related]
39. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. Haldorsen IS, Kråkenes J, Krossnes BK, Mella O, Espeland A. AJNR Am J Neuroradiol; 2009 Apr 10; 30(4):744-51. PubMed ID: 19164442 [Abstract] [Full Text] [Related]
40. Glioblastoma and primary central nervous system lymphoma: Preoperative differentiation by using MRI-based 3D texture analysis. Xiao DD, Yan PF, Wang YX, Osman MS, Zhao HY. Clin Neurol Neurosurg; 2018 Oct 10; 173():84-90. PubMed ID: 30092408 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]